Molecular epidemiology of a carbapenem-resistant Serratia marcescens outbreak during the COVID-19 pandemic
IntroductionSerratia marcescens is a significant causative agent of hospital-acquired infections (HAIs), particularly in intensive care units (ICUs). Carbapenem resistance represents a major concern in HAI management, as carbapenem-resistant bacteria can trigger outbreaks in hospital settings. While...
Saved in:
| Main Authors: | Letícia Fernandes da Rocha, Grazielle Motta Rodrigues, Gabriela Simões de Oliveira, Aymê Duarte Echevarria, Priscila Wink, Fabiana Volpato, Mayana Berdichevski, Larissa Lutz, Dariane Castro Pereira, Afonso Luís Barth, Andreza Francisco Martins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1525543/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmidome analyses of Klebsiella pneumoniae co-producing blaKPC-2 and blaNDM-1 in Southern Brazil: characterisation of mobile genetic elements
by: Mayana Kieling Hernandez Berdichevski, et al.
Published: (2025-05-01) -
Genetic basis of carbapenem-resistant clinical Serratia marcescens in Japan
by: Hazim O. Khalifa, et al.
Published: (2025-05-01) -
Global genomic epidemiology and plasmid-mediated dissemination of blaKPC and blaNDM in the Serratia marcescens complex
by: Xiao Liu, et al.
Published: (2025-01-01) -
Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19
by: Otávio von Ameln Lovison, et al.
Published: (2025-05-01) -
Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to characterize sepsis?
by: Rafaela Ramalho Guerra, et al.
Published: (2025-08-01)